Advertisement
Screener

SERA PROGNOSTICS, INC. (SERA) Increase (Decrease) in Contract with Customer, Liability

2.8 / 5 stars · 68/120 Roast Me

SERA PROGNOSTICS, INC. Increase (Decrease) in Contract with Customer, Liability

SERA PROGNOSTICS, INC. (SERA) reported Increase (Decrease) in Contract with Customer, Liability of -$19.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInContractWithCustomerLiability · last filed 2026-08-12

  • SERA PROGNOSTICS, INC. increase (decrease) in contract with customer, liability for the quarter ending 2026-06-30 was -$14.00K.
  • SERA PROGNOSTICS, INC. increase (decrease) in contract with customer, liability for the quarter ending 2026-03-31 was -$5.00K.
  • SERA PROGNOSTICS, INC. increase (decrease) in contract with customer, liability for the quarter ending 2025-12-31 was -$4.00K.
  • SERA PROGNOSTICS, INC. increase (decrease) in contract with customer, liability for the quarter ending 2025-09-30 was $99.00K.
  • SERA PROGNOSTICS, INC. increase (decrease) in contract with customer, liability for fiscal 2025 was $92.00K.
  • SERA PROGNOSTICS, INC. increase (decrease) in contract with customer, liability for fiscal 2024 was -$12.00K, a 100.11% decline from fiscal 2023.
  • SERA PROGNOSTICS, INC. increase (decrease) in contract with customer, liability for fiscal 2023 was $11.15M, a 86.96% increase from fiscal 2022.
  • SERA PROGNOSTICS, INC. increase (decrease) in contract with customer, liability for fiscal 2022 was $5.97M, a 91.46% increase from fiscal 2021.
Period endIncrease (Decrease) in Contract with Customer, Liability 3 monthIncrease (Decrease) in Contract with Customer, Liability 6 monthIncrease (Decrease) in Contract with Customer, Liability 9 monthIncrease (Decrease) in Contract with Customer, Liability 12 month
2026-06-30-$14.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12
-$19.00K
10-Q · filed 2026-08-12
-$23.00K
derived: sum of 3 quarters · filed 2026-08-12
$76.00K
derived: sum of 4 quarters · filed 2026-08-12
2026-03-31-$5.00K
10-Q · filed 2026-05-06
-$9.00K
derived: sum of 2 quarters · filed 2026-05-06
$90.00K
derived: sum of 3 quarters · filed 2026-05-06
$89.00K
derived: sum of 4 quarters · filed 2026-08-12
2025-12-31-$4.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18
$95.00K
derived: sum of 2 quarters · filed 2026-03-18
$94.00K
derived: sum of 3 quarters · filed 2026-08-12
$92.00K
10-K · filed 2026-03-18
2025-09-30$99.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13
$98.00K
derived: sum of 2 quarters · filed 2026-08-12
$96.00K
10-Q · filed 2025-11-13
$93.00K
derived: sum of 4 quarters · filed 2026-08-12
2025-06-30-$1.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12
-$3.00K
10-Q · filed 2026-08-12
-$6.00K
derived: sum of 3 quarters · filed 2026-08-12
-$8.00K
derived: sum of 4 quarters · filed 2026-08-12
2025-03-31-$2.00K
10-Q · filed 2026-05-06
-$5.00K
derived: sum of 2 quarters · filed 2026-05-06
-$7.00K
derived: sum of 3 quarters · filed 2026-05-06
-$9.00K
derived: sum of 4 quarters · filed 2026-05-06
2024-12-31-$3.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18
-$5.00K
derived: sum of 2 quarters · filed 2026-03-18
-$7.00K
derived: sum of 3 quarters · filed 2026-03-18
-$12.00K
10-K · filed 2026-03-18
2024-09-30-$2.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13
-$4.00K
derived: sum of 2 quarters · filed 2025-11-13
-$9.00K
10-Q · filed 2025-11-13
$11.19M
derived: sum of 4 quarters · filed 2025-11-13
2024-06-30-$2.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06
-$7.00K
10-Q · filed 2025-08-06
$11.19M
derived: sum of 3 quarters · filed 2025-08-06
$11.18M
derived: sum of 4 quarters · filed 2025-08-06
2024-03-31-$5.00K
10-Q · filed 2025-05-07
$11.19M
derived: sum of 2 quarters · filed 2025-05-07
$11.18M
derived: sum of 3 quarters · filed 2025-05-07
$11.16M
derived: sum of 4 quarters · filed 2025-05-07
2023-12-31$11.20M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-19
$11.19M
derived: sum of 2 quarters · filed 2025-03-19
$11.17M
derived: sum of 3 quarters · filed 2025-03-19
$11.15M
10-K · filed 2025-03-19
2023-09-30-$10.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06
-$28.00K
derived: sum of 2 quarters · filed 2024-11-06
-$42.00K
10-Q · filed 2024-11-06
$5.95M
derived: sum of 4 quarters · filed 2024-11-06
2023-06-30-$18.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07
-$32.00K
10-Q · filed 2024-08-07
$5.96M
derived: sum of 3 quarters · filed 2024-08-07
$5.95M
derived: sum of 4 quarters · filed 2024-08-07
2023-03-31-$14.00K
10-Q · filed 2024-05-08
$5.98M
derived: sum of 2 quarters · filed 2024-05-08
$5.97M
derived: sum of 3 quarters · filed 2024-05-08
$5.96M
derived: sum of 4 quarters · filed 2024-05-08
2022-12-31$5.99M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20
$5.98M
derived: sum of 2 quarters · filed 2024-03-20
$5.97M
derived: sum of 3 quarters · filed 2024-03-20
$5.97M
10-K · filed 2024-03-20
2022-09-30-$11.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08
-$21.00K
derived: sum of 2 quarters · filed 2023-11-08
-$25.00K
10-Q · filed 2023-11-08
$3.09M
derived: sum of 4 quarters · filed 2023-11-08
2022-06-30-$10.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09
-$14.00K
10-Q · filed 2023-08-09
$3.10M
derived: sum of 3 quarters · filed 2023-08-09
$3.10M
derived: sum of 4 quarters · filed 2023-08-09
2022-03-31-$4.00K
10-Q · filed 2023-05-10
$3.11M
derived: sum of 2 quarters · filed 2023-05-10
$3.11M
derived: sum of 3 quarters · filed 2023-05-10
$3.11M
derived: sum of 4 quarters · filed 2023-05-10
2021-12-31$3.12M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22
$3.12M
derived: sum of 2 quarters · filed 2023-03-22
$3.12M
derived: sum of 3 quarters · filed 2023-03-22
$3.12M
10-K · filed 2023-03-22
2021-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09
$0.00
derived: sum of 2 quarters · filed 2022-11-09
$0.00
10-Q · filed 2022-11-09
2021-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10
$0.00
10-Q · filed 2022-08-10
2021-03-31$0.00
10-Q · filed 2022-05-10
2020-12-31$0.00
10-K · filed 2022-03-29

Similar stocks

Stock NameCountryMarket CapPE Ratio
AMERICAN SHARED HOSPITAL SERVICES (AMS)United States$0.010B-5.64
Advanced Biomed Inc. (ADVB)$0.009B
Aclarion, Inc. (ACON)United States$0.008B
BioNexus Gene Lab Corp (BGLC)$0.004B
Freenome, Inc. (FRNM)United States$0.143B
EXAGEN INC. (XGN)United States$0.212B-5.95
BIODESIX INC (BDSX)United States$0.312B
Fulgent Genetics, Inc. (FLGT)United States$0.593B-6.70
Lumexa Imaging Holdings, Inc. (LMRI)United States$0.951B
CASTLE BIOSCIENCES INC (CSTL)United States$1.074B-37.45